Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.65%
SPX
-0.05%
IXIC
+0.13%
FTSE
-1.11%
N225
0.00%
AXJO
0.00%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
Health Care
jnj
Johnson & Johnson
NYSE: JNJ
+0.84 (+0.43%)
196.09
USD
At close at Nov 14, 21:34 UTC
Summary
News
Signals
Benchmarks
Financials

Overview

Loading chart...

Key Stats

Market Cap
471.87B
Dividend Yield
0.00%
P/E Ratio
18.79
EPS
5.84
Revenue
88.82B
Avg. Volume
7.81M

Recently from Cashu

publisher logo
Cashu

Johnson & Johnson's JLABS Partners with EXoPERT to Advance Cancer Diagnostics Innovation

4 days ago
publisher logo
Cashu

Johnson & Johnson's JLABS Welcomes EXoPERT for Cancer Diagnostics Innovation

6 days ago
publisher logo
Cashu

Johnson & Johnson Gains FDA Approval for Darzalex Faspro, Enhancing Cancer Treatment Options

7 days ago

About

What does JNJ do?
Johnson & Johnson, headquartered in New Brunswick, New Jersey, employs 131,900 people and focuses on healthcare through its Innovative Medicine and MedTech segments. Innovative Medicine targets various therapeutic areas, while MedTech offers products for orthopedic and cardiovascular interventions.
Sector
💻 Health Care
IPO
CEO
Employees
138,100
Headquarters
New Jersey, USA
Website
http://www.jnj.com
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.